Wall Street Journal Exclusive | Warburg Pincus Near Over $7 Billion Deal for Specialty-Pharmacy Company This post was originally published on this site. PANTHERx Rare has been owned by a group of private-equity firms since 2022. By Lauren Thomas,Mark MaurerJuly 10, 2026July 10, 2026No comment
